Active ingredientTetrazepamCat. No. P-T078-001CAS 10379-14-3Family · Pharmaceutical analytical standards
Tetrazepam
A benzodiazepine used mainly as a muscle relaxant for muscle contractures and spasms, widely prescribed in France, Germany, Austria, Belgium and Spain until its withdrawal from the European Union market in 2013. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It is an unusual benzodiazepine: in its molecule a cyclohexenyl ring takes the place of the phenyl ring found in almost all the others.
Go to the active ingredient →Active ingredientTetrazepamCat. No. P-T078-001CAS 10379-14-3
Pharmacopoeial impurityTetrazepam EP Impurity BCat. No. P-T078-002CAS 1789-33-9
Pharmacopoeial impurityTetrazepam EP Impurity CCat. No. P-T078-003CAS 1784-78-7
Pharmacopoeial impurityTetrazepam EP Impurity ECat. No. P-T078-004CAS 10379-11-0No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
ImpurityTetrazepam impurity C CRSEDQM code Y0000008Family TetrazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.